Cite
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.
MLA
Spirito, Alessandro, et al. “Predictive Value of the Thrombotic Risk Criteria Proposed in the 2023 ESC Guidelines for the Management of ACS: Insights from a Large PCI Registry.” European Heart Journal. Cardiovascular Pharmacotherapy, vol. 10, no. 1, Jan. 2024, pp. 11–19. EBSCOhost, https://doi.org/10.1093/ehjcvp/pvad069.
APA
Spirito, A., Cao, D., Sartori, S., Sharma, A., Smith, K. F., Vogel, B., Kamaleldin, K., Koshy, A. N., Feng, Y., Power, D., Baber, U., Krishnamoorthy, P., Dangas, G., Kini, A., Sharma, S. K., & Mehran, R. (2024). Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry. European Heart Journal. Cardiovascular Pharmacotherapy, 10(1), 11–19. https://doi.org/10.1093/ehjcvp/pvad069
Chicago
Spirito, Alessandro, Davide Cao, Samantha Sartori, Ashutosh Sharma, Kenneth F Smith, Birgit Vogel, Karim Kamaleldin, et al. 2024. “Predictive Value of the Thrombotic Risk Criteria Proposed in the 2023 ESC Guidelines for the Management of ACS: Insights from a Large PCI Registry.” European Heart Journal. Cardiovascular Pharmacotherapy 10 (1): 11–19. doi:10.1093/ehjcvp/pvad069.